154 related articles for article (PubMed ID: 2032422)
1. Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues.
Ballin M; Mackay AR; Hartzler JL; Nason A; Pelina MD; Thorgeirsson UP
Clin Exp Metastasis; 1991; 9(2):179-89. PubMed ID: 2032422
[TBL] [Abstract][Full Text] [Related]
2. Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.
Llorens A; Vinyals A; Alia P; López-Barcons L; Gonzalez-Garrigues M; Fabra A
Mol Carcinog; 1997 May; 19(1):54-66. PubMed ID: 9180929
[TBL] [Abstract][Full Text] [Related]
3. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
4. Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats.
Ronai Z; Lau YY; Cohen LA
Mol Carcinog; 1991; 4(2):120-8. PubMed ID: 2043252
[TBL] [Abstract][Full Text] [Related]
5. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
Thompson TA; Haag JD; Gould MN
Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
[TBL] [Abstract][Full Text] [Related]
6. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
Chiodino C; Jones RF; Ethier SP
Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
[TBL] [Abstract][Full Text] [Related]
7. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels.
Zhang R; Haag JD; Gould MN
Cancer Res; 1990 Jul; 50(14):4286-90. PubMed ID: 2194653
[TBL] [Abstract][Full Text] [Related]
8. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
9. II. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rats.
Karmali RA; Chao CC; Basu A; Modak M
Anticancer Res; 1989; 9(4):1169-74. PubMed ID: 2510583
[TBL] [Abstract][Full Text] [Related]
10. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.
Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R
Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
[TBL] [Abstract][Full Text] [Related]
13. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.
Ballin M; Gomez DE; Sinha CC; Thorgeirsson UP
Biochem Biophys Res Commun; 1988 Aug; 154(3):832-8. PubMed ID: 3044367
[TBL] [Abstract][Full Text] [Related]
14. Ha-ras-1 oncogene mutations in mammary epithelial cells do not contribute to initiation of spontaneous mammary tumorigenesis in rats.
Cha RS; Guerra L; Thilly WG; Zarbl H
Carcinogenesis; 1996 Nov; 17(11):2519-24. PubMed ID: 8968072
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of gene expression in ras-resistant and ras-sensitive cells.
Tuck AB; Wilson SM; Khokha R; Chambers AF
J Natl Cancer Inst; 1991 Apr; 83(7):485-91. PubMed ID: 1848638
[TBL] [Abstract][Full Text] [Related]
16. Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands.
Sakai H; Ogawa K
Int J Cancer; 1991 Aug; 49(1):140-4. PubMed ID: 1874567
[TBL] [Abstract][Full Text] [Related]
17. Expression of the c-Ha-ras and neu oncogenes in DMBA-induced, anti-estrogen-treated rat mammary tumors.
Vuorio T; Wärri A; Sandberg M; Alitalo K; Vuorio E
Int J Cancer; 1988 Nov; 42(5):774-9. PubMed ID: 2972630
[TBL] [Abstract][Full Text] [Related]
18. Activation of ras oncogenes preceding the onset of neoplasia.
Kumar R; Sukumar S; Barbacid M
Science; 1990 Jun; 248(4959):1101-4. PubMed ID: 2188364
[TBL] [Abstract][Full Text] [Related]
19. Expression of stromelysin-1 and TIMP-1 in the involuting mammary gland and in early invasive tumors of the mouse.
Li F; Strange R; Friis RR; Djonov V; Altermatt HJ; Saurer S; Niemann H; Andres AC
Int J Cancer; 1994 Nov; 59(4):560-8. PubMed ID: 7960227
[TBL] [Abstract][Full Text] [Related]
20. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
Ichikawa T; Kyprianou N; Isaacs JT
Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
